Literature DB >> 29749867

Ensuring sustainability of software tools and services by cooperation with a research infrastructure.

Wolfgang Kuchinke1, Christian Ohmann2, Holger Stenzhorn3, Alberto Anguista4, Stelios Sfakianakis5, Norbert Graf3, Jacques Demotes6.   

Abstract

Sustainability of project output and especially of the maintenance and further development of software is of growing concern for the research community. In the personalized medicine project p-medicine solutions that address this sustainability problem were developed and discussed in a workshop. They involve a number of interrelated and mutually supportive measures including the creation of a service center, building modular software, using common data standards, mutual service exchange with a research infrastructure, Open Source and fee-based software provision, joint promotion and deployment of tools in a regulated, clinical trial situation. These ideas join a nascent literature seeking to understand how project output can be put into a sustainable environment and to suggest solutions that may be useful for academic projects in general.

Keywords:  ECRIN; certification; clinical trials; good clinical practice; personalized medicine; research infrastructure; services; software; sustainability

Year:  2016        PMID: 29749867     DOI: 10.2217/pme.15.43

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  1 in total

Review 1.  Open-source Software Sustainability Models: Initial White Paper From the Informatics Technology for Cancer Research Sustainability and Industry Partnership Working Group.

Authors:  Ye Ye; Seemran Barapatre; Michael K Davis; Keith O Elliston; Christos Davatzikos; Andrey Fedorov; Jean-Christophe Fillion-Robin; Ian Foster; John R Gilbertson; Andras Lasso; James V Miller; Martin Morgan; Steve Pieper; Brigitte E Raumann; Brion D Sarachan; Guergana Savova; Jonathan C Silverstein; Donald P Taylor; Joyce B Zelnis; Guo-Qiang Zhang; Jamie Cuticchia; Michael J Becich
Journal:  J Med Internet Res       Date:  2021-12-02       Impact factor: 5.428

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.